PLK1 is frequently overexpressed in almost all cancers (Fig. EV1A), especially in advanced prostate cancer (Fig. EV1B and Fig. 1A) and showing poor prognosis (Fig. EV1C). This evidence concerns the gene PLK1 and prostate carcinoma.